Genomma Lab Internacional, S.A.B. de C.V. GNMLF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 69.53% | 31.57% | -0.01% | -1.45% | -36.20% |
| Total Depreciation and Amortization | 0.59% | 2.32% | 6.51% | 1.38% | 32.41% |
| Total Amortization of Deferred Charges | 72.34% | 72.34% | 72.34% | 72.34% | -32.64% |
| Total Other Non-Cash Items | -3.53% | -28.22% | -36.99% | -50.58% | 30.35% |
| Change in Net Operating Assets | -88.28% | -1,029.32% | -94.05% | -6.90% | -113.75% |
| Cash from Operations | -0.03% | -36.76% | -33.30% | -29.70% | -24.36% |
| Capital Expenditure | -8.76% | -62.58% | -81.93% | -104.15% | -162.82% |
| Sale of Property, Plant, and Equipment | 237.96% | 382.96% | -16.44% | -28.33% | -16.61% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 261.09% | 137.87% | 93.78% | 84.46% | 107.60% |
| Cash from Investing | -16.53% | 23.26% | 4.11% | -2.85% | 61.47% |
| Total Debt Issued | -5.45% | -31.33% | 16.03% | 17.67% | 16.98% |
| Total Debt Repaid | 2.14% | 31.98% | -2.21% | 8.16% | -0.55% |
| Issuance of Common Stock | 6.81% | 6.81% | 8.61% | 8.61% | -4.10% |
| Repurchase of Common Stock | -7.58% | -9.77% | -9.50% | -12.19% | 7.66% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -11.59% | -85.96% | -4.04% | 3.77% | 11.25% |
| Other Financing Activities | 22.92% | 19.75% | 16.63% | 8.96% | -7.86% |
| Cash from Financing | -12.74% | -77.81% | 64.08% | 69.51% | 50.40% |
| Foreign Exchange rate Adjustments | 57.52% | -111.85% | -424.06% | -377.80% | -191.24% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.39% | -108.56% | -51.95% | -17.51% | 1,254.19% |